Cargando…

Update on schizophrenia and bipolar disorder: focus on cariprazine

Schizophrenia and bipolar disorder are severe psychiatric disorders that are frequently associated with persistent symptoms and significant dysfunction. While there are a multitude of psychopharmacologic agents are available for treatment of these illnesses, suboptimal response and significant adver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roberts, Rona Jeannie, Findlay, Lillian Jan, El-Mallakh, Peggy L, El-Mallakh, Rif S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966692/ https://www.ncbi.nlm.nih.gov/pubmed/27524901 http://dx.doi.org/10.2147/NDT.S97616

Ejemplares similares

Management of bipolar I depression: clinical utility of lurasidone
por: Findlay, Lillian Jan, et al.
Publicado: (2015)

Current and Emerging Therapies for the Management of Bipolar Disorders
por: El-Mallakh, Rif S., et al.
Publicado: (2011)

Role of endogenous ouabain in the etiology of bipolar disorder
por: El-Mallakh, Rif S., et al.
Publicado: (2021)

Strategies to improve medication adherence in patients with schizophrenia: the role of support services
por: El-Mallakh, Peggy, et al.
Publicado: (2015)

Transdermal Asenapine in Schizophrenia: A Systematic Review
por: Carrithers, Brennan, et al.
Publicado: (2020)

Endogenous Cardiac Steroids in Bipolar Disorder: State of the Art
por: El-Mallakh, Rif S., et al.
Publicado: (2022)

Xanomeline-Trospium and Muscarinic Involvement in Schizophrenia
por: Kidambi, Neil, et al.
Publicado: (2023)

Review of depot aripiprazole for schizophrenia
por: Motiwala, Farha Bilal, et al.
Publicado: (2013)

Cardiac Glycosides in Human Physiology and Disease: Update for Entomologists
por: El-Mallakh, Rif S., et al.
Publicado: (2019)

Cariprazine exerts antimanic properties and interferes with dopamine D(2) receptor β-arrestin interactions
por: Gao, Yonglin, et al.
Publicado: (2015)

Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures
por: Brown, Martin E, et al.
Publicado: (2010)

Olfactory Neuroepithelial Neural Progenitor Cells from Subjects with Bipolar I Disorder
por: Gao, Yonglin, et al.
Publicado: (2017)

Nebulized Lidocaine in COVID-19, An Hypothesis
por: Ali, Ziad A., et al.
Publicado: (2020)

NMDA receptor inhibition prevents intracellular sodium elevations in human olfactory neuroepithelial precursors derived from bipolar patients
por: Gao, Yonglin, et al.
Publicado: (2022)

A case of iloperidone overdose in a 27-year-old man with cocaine abuse
por: Amon, Jin, et al.
Publicado: (2016)

New developments in the management of schizophrenia and bipolar disorder: potential use of cariprazine
por: Werner, Felix-Martin, et al.
Publicado: (2015)

Antidepressant discontinuation in treatment resistant depression
por: Ali, Ziad A., et al.
Publicado: (2019)

Frequency of Modification of Pharmacological Treatment Is Equivalent for Virtual and In-Person Psychiatric Visits
por: Mumtaz, Amal, et al.
Publicado: (2023)

Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and Schizophrenia
por: Culpepper, Larry, et al.
Publicado: (2022)

No NLRP3 Inflammasome Expression in the Ouabain Animal Model of Bipolar Disorder
por: Farooqui, Ali A, et al.
Publicado: (2022)

Inhibition of endogenous ouabain by atrial natriuretic peptide is a guanylyl cyclase independent effect
por: Tegin, Gulay, et al.
Publicado: (2021)

Glial-specific gene alterations associated with manic behaviors
por: Gao, Yonglin, et al.
Publicado: (2013)

Cariprazine hydrochloride for schizophrenia
Publicado: (2021)

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili, Nizar
Publicado: (2012)

Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis
por: Durgam, Suresh, et al.
Publicado: (2017)

Cariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials
por: Do, André, et al.
Publicado: (2021)

Relationship Between Plasma Concentrations and Clinical Effects of Cariprazine in Patients With Schizophrenia or Bipolar Mania
por: Periclou, Antonia, et al.
Publicado: (2019)

Cariprazine: Patients with Treatment-Resistant Schizophrenia
por: Aubel, Thomas
Publicado: (2021)

Cariprazine’s efficacy in treating affective symptoms – pooled data from schizophrenia and bipolar depression trials
por: Mcintyre, R., et al.
Publicado: (2022)

Cariprazine for Treating Schizophrenia, Mania, Bipolar Depression, and Unipolar Depression: A Review of Its Efficacy
por: Tarzian, Martin, et al.
Publicado: (2023)

Patient satisfaction and treatment outcomes as quality indicators for mental health services
por: Howard, Patricia Byrd, et al.
Publicado: (2004)

Cariprazine — an Alternative Treatment for Clozapine-resistant Schizophrenia?
por: Montgomery, Adam, et al.
Publicado: (2023)

Case series: Cariprazine in early-onset schizophrenia
por: Ivanova, Elena, et al.
Publicado: (2023)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Batinic, Borjanka, et al.
Publicado: (2021)

Chlordiazepoxide-induced delirium in a patient undergoing alcohol withdrawal: a case report
por: Arabadjief, Melissa A., et al.
Publicado: (2022)

A new generation of antipsychotics: pharmacology and clinical utility of cariprazine in schizophrenia
por: Caccia, Silvio, et al.
Publicado: (2013)

Clinical effects of Cariprazine and their relationship with polymorphisms of dopamine and serotonin receptors: preliminary results from a prospective study on schizophrenia and bipolar disorder
por: De Pieri, M., et al.
Publicado: (2022)

Effects of somatic treatments on suicidal ideation and completed suicides
por: Hawkins, Elise M, et al.
Publicado: (2021)

Cariprazine’s efficacy in treating depressive symptoms – pooled data from schizophrenia, bipolar depression and major depression trials
por: McIntyre, R. S., et al.
Publicado: (2023)

Cariprazine in the treatment of schizophrenia: a proof-of-concept trial
por: Durgam, Suresh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mkdo0pl66sons5havasv4a07ra